12/06/23

One-Year Clinical Outcomes of Subcutaneous Infliximab Maintenance Therapy Compared With Intravenous Infliximab Maintenance Therapy in Patients With Inflammatory Bowel Disease: A Prospective Cohort Study 

Sung Noh Hong, MD, PhD, Joo Hye Song, MD, PhD, Sung Jin Kim, MS, Yoon Ha Park, RN, Chang Wan Choi, MD, Ji Eun Kim, MD, PhD, Eun Ran Kim, MD, PhD, Dong Kyung Chang, MD, PhD, Young-Ho Kim, MD,…
12/06/23

Cumulative exposure to immunomodulators increases risk of cervical neoplasia in women with inflammatory bowel disease

J E Kreijne 1 2 , R L Goetgebuer 1 , N S Erler 3 4 , N K De Boer 2 , A G Siebers 5 , G Dijkstra 6 , F A van Kemenade 7 , F Hoentjen…
12/06/23

Systematic Review of Sarcopenia in Inflammatory Bowel Disease

Hala Fatani, Adina Olaru, Rebecca Stevenson, Philip Atherton, Matthew Brook, Gordon MoranCLINICAL NUTRITION Published:June 02, 2023DOI:https://doi.org/10.1016/j.clnu.2023.05.002 Summary IntroductionThere is growing evidence of increased muscle atrophy in IBD patients, likely resulting in a higher sarcopenia prevalence in IBD. The aims of…
12/06/23

Long-term outcomes of vedolizumab in inflammatory bowel disease: the Swedish prospective multicentre SVEAH extension study

Isabella Visuri 1 , Carl Eriksson 2 3 , Sara Karlqvist 2 , Byron Lykiardopoulos 4 , Per Karlén 5 , Olof Grip 6 , Charlotte Söderman 7 , Sven Almer 8 9 , Erik Hertervig 6 , Jan Marsal…
07/06/23

Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH study

Carl Eriksson 1 , Sara Rundquist 2 , Vyron Lykiardopoulos 3 , Ruzan Udumyan 4 , Per Karlén 5 , Olof Grip 6 , Charlotte Söderman 7 , Sven Almer 8 , Erik Hertervig 9 , Jan Marsal 9 , …
07/06/23

Iron deficiency anemia impacts disease progression and healthcare resource consumption in patients with inflammatory bowel disease: a real-world evidence study

Gionata Fiorino https://orcid.org/0000-0001-5623-2968, Jean-Frederic Colombel, […], and Ioannis E. Koutroubakis Αυτή η διεύθυνση ηλεκτρονικού ταχυδρομείου προστατεύεται από τους αυτοματισμούς αποστολέων ανεπιθύμητων μηνυμάτων. Χρειάζεται να ενεργοποιήσετε τη JavaScript για να μπορέσετε να τη δείτε.tic Advances in Gastroenterology, Volume 16, January-December 2023 https://doi.org/10.1177/17562848231177153 Abstract Background:Iron deficiency anemia (IDA) is a common extraintestinal manifestation of inflammatory bowel disease (IBD), affecting around one-third of patients. Objective:To…
02/06/23

Bedside Intestinal Ultrasound Predicts Disease Severity and the Disease Distribution of Pediatric Patients With Inflammatory Bowel Disease: A Pilot Cross-sectional Study

Mallory Chavannes, MD, MHSc, Lara Hart, MD, MSc, Panteha Hayati Rezvan, PhD, Jonathan R Dillman, MD, MS, MSc, D Brent Polk, MDInflammatory Bowel Diseases, izad083, https://doi.org/10.1093/ibd/izad083 Abstract BackgroundIntestinal ultrasound (IUS) is a noninvasive tool to assess bowel inflammation. There is…
18/05/23

Impact of Vedolizumab on Extraintestinal Manifestations in Inflammatory Bowel Disease: Results From a Descriptive, Retrospective, Real-world Study

Uri Kopylov, MD, Johan Burisch, DMSc, Shomron Ben-Horin, MD, Fiona Braegger, DVM, Alonso Fernández-Nistal, PhD, Nuria Lara, MD, Henriette Sophie Heinrich, PD, Stephan R Vavricka, MDInflammatory Bowel Diseases, izad075, https://doi.org/10.1093/ibd/izad075 Published: 09 May 2023 Article history Abstract BackgroundPatients with inflammatory…
09/05/23

Systematic Review and Meta-analysis: The Association Between Serum Ustekinumab Trough Concentrations and Treatment Response in Inflammatory Bowel Disease  

Abhinav Vasudevan, MD, Vivek Tharayil, MD, Laura H Raffals, MD, David H Bruining, MD, Michelle Becker, PharmD, Mohammad Hassan Murad, MD, Edward V Loftus, Jr, MDInflammatory Bowel Diseases 2023 Apr 18 doi: 10.1093/ibd/izad065 Abstract BackgroundOptimizing therapy and monitoring response are…
09/05/23

Increasing risk of lymphoma over time in Crohn’s disease but not in ulcerative colitis: a Scandinavian cohort study

Ola Olén 1 , Karin E Smedby 2 , Rune Erichsen 3 , Lars Pedersen 4 , Jonas Halfvarson 5 , Åsa Hallqvist-Everhov 6 , Nicklas Bryder 6 ; SWIBREG study group; Johan Askling 6 , Anders Ekbom 6 , …
09/05/23

Comparative Efficacy of Infliximab Versus Tofacitinib for Inducing Remission in Biologic Naive Ulcerative Colitis: A Propensity Matched Study

Emily C L Wong 1 , Shahin Merat 1 , Cristina Monaco 1 , Parambir S Dulai 2 , Vipul Jairath 3 , John K Marshall 1 , Walter Reinisch 4 , Neeraj Narula 5 6 Dig Dis Sci 2023…
09/05/23

Comparing Patient-Reported Outcomes Among Anti-TNF-Experienced Patients with Crohn’s Disease Initiating Vedolizumab Versus Ustekinumab

Michael D Kappelman 1 , J D Lewis 2 , X Zhang 3 , F C Lin 3 , L Weisbein 3 , W Chen 3 , J Burris 4 , J E Dorand 5 , L E Parlett 6…